Li CJ, Averboukh L, Pardee AB. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin.
J Biol Chem. 1993;268:22463 - 22468.
Guiraud P, Steiman R, Campos-Takaki GM, et al. Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone.
Planta Med. 1994;60:373 - 374.
Oswald EH. Lapacho.
Br J Phytother. 1993/1994;3:112 - 117.
Bailly C. Topoisomerase I poisons and suppressors as anticancer drugs.
Curr Med Chem.
2000;7:39-58.
Dolan ME, Frydman B, Thompson CB, et al. Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents.
Anticancer Drugs.
1998;9:437-448.
Huang L, Pardee AB. Beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells.
Mol Med.
1999;5:711-720.
Hueber A, Esser P, Heimann K, et al. The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells.
Exp Eye Res.
1998;67:525-530.
Krishnan P, Bastow KF. Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and beta-lapachone.
Cancer Chemother Pharmacol.
2001;47:187-198.
Li Y, Li CJ, Yu D, Pardee AB. Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells.
Mol Med.
2000;6:1008-1015.
Neder K, Marton LJ, Liu LF. Reaction of beta-lapachone and related naphthoquinones with 2-mercaptoethanol: a biomimetic model of topoisomerase II poisoning by quinones.
Cell Mol Biol.
1998;44:465-474.
Planchon SM, Pink JJ, Tagliarino C, et al. Beta-lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
Exp Cell Res.
2001;267(1):95-106.
Carvalho LH, Rocha EM, Raslan DS, et al.
In vitro
activity of natural and synthetic naphthoquinones against erythrocytic stages of
Plamodium falciparum.
Braz J Med Biol Res. 1988;21(3):485-487.
Guiraud P, Steiman R, Campos-Takaki GM, et al. Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone.
Planta Med.
1994;60:373 - 374.
Lima NM, dos Santos AF, Porfirio Z, et al. Toxicity of lapachol and isolapachol and their potassium salts against
Biomphalaria glabrata,
Schistosoma mansoni cercariae,
Artemia salina
and
Tilapia nilotica.
Acta Trop.
2002;83:43-47.
Portillo A, Vila R, Freixa B, Adzet T, Canigueral S. Antifungal activity of Paraguayan plants used in traditional medicine.
J Ethnopharmacol.
2001;76:93-98.
Santos AF, Ferraz PA, de Abreu FC, et al. Molluscicidal and trypanocidal activities of lapachol derivatives.
Planta Med.
2001;67:92-93.
Miranda FG, Vilar JC, Alves IA, Cavalcanti SC, Antoniolli AR. Antinociceptive and antiedematogenic properties and acute toxicity of
Tabebuia avellanedae
Lor. ex Griseb. inner bark aqueous extract.
BMC Pharmacol.
2001;1:6.
Muller K, Sellmer A, Wiegrebe W. Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth.
J Nat Prod.
1999;62(8):1134-1136.
Goel RK, Pathak NK, Biswas M, et al. Effect of lapachol, a naphthaquinone isolated from
Tectona grandis, on experimental peptic ulcer and gastric secretion.
J Pharm Pharmacol.
1987;39(2):138-140.
Guerra MO, Mazoni AS, Brandao MA, Peters VM. Interceptive effect of lapachol in rats.
Contraception.
1999;60(5):305-307.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.